首页 › 基金 › PERCEPTIVE ADVISORS LLC › AVLN

PERCEPTIVE ADVISORS LLC 对 AVLN 的持仓历史

AVALYN PHARMA INC · 医疗保健

PERCEPTIVE ADVISORS LLC 在 Q2 2026 的 13F 申报中披露持有 AVLN(AVALYN PHARMA INC)2,675,296 股,市值约 US$88.1M,约占其申报组合的 1.40%,在其申报持仓中市值排名第 24 位。 PERCEPTIVE ADVISORS LLC 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)2.68M 股
申报持仓市值$88.07M
组合权重1.40%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

PERCEPTIVE ADVISORS LLC 对 AVLN 的持仓演变

PERCEPTIVE ADVISORS LLC 于 Q2 2026 首次披露 AVLN 持仓:2,675,296 股(约 US$88.1M)。

逐季持仓明细

季度股数金额变化
Q2 2026 2.68M $88.07M 新进

关于 AVLN 与 13F 数据

AVLN(AVALYN PHARMA INC)属于医疗保健行业。我们追踪的基金中还有 97 只申报持有 AVLN,申报仓位最大的包括:Novo Holdings A/S (US$127.8M), SR ONE CAPITAL MANAGEMENT, LP (US$108.9M), MONTANOVA CAPITAL, LLC (US$82.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 AVLN 的基金

查看 AVLN 的全部基金持有人 →

常见问题

How long has PERCEPTIVE ADVISORS LLC held AVLN?

PERCEPTIVE ADVISORS LLC has disclosed AVLN holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is PERCEPTIVE ADVISORS LLC's current position in AVLN?

As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 2.68M shares of AVLN (AVALYN PHARMA INC), valued at $88.07M, representing 1.40% of its reported portfolio and ranking #24.

Has PERCEPTIVE ADVISORS LLC been buying or selling AVLN?

In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC newly opened its position in AVLN.

Which other funds hold AVLN?

Other major institutional holders of AVLN include Novo Holdings A/S, SR ONE CAPITAL MANAGEMENT, LP, MONTANOVA CAPITAL, LLC, among 97 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.